Joeri L Aerts
Overview
Explore the profile of Joeri L Aerts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dhaese S, Laeremans T, den Roover S, Allard S, Vanham G, Aerts J
Pharmaceutics
. 2022 Jul;
14(7).
PMID: 35890284
A major determinant for the success of mRNA-based vaccines is the composition of the nanoparticles (NPs) used for formulation and delivery. Cationic peptides represent interesting candidate carriers for mRNA, since...
12.
Kalus P, De Munck J, Vanbellingen S, Carreer L, Laeremans T, Broos K, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563257
Recently, a paradigm shift has been established for oncolytic viruses (OVs) as it was shown that the immune system plays an important role in the specific killing of tumor cells...
13.
Verbruggen L, Ates G, Lara O, De Munck J, Villers A, De Pauw L, et al.
Mol Psychiatry
. 2022 Feb;
27(4):2355-2368.
PMID: 35181756
The cystine/glutamate antiporter system x has been identified as the major source of extracellular glutamate in several brain regions as well as a modulator of neuroinflammation, and genetic deletion of...
14.
Tijtgat J, De Munck J, Dufait I, Schwarze J, Van Riet I, Franceschini L, et al.
Front Immunol
. 2021 Nov;
12:733506.
PMID: 34777344
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not...
15.
Kortekaas Krohn I, Aerts J, Breckpot K, Goyvaerts C, Knol E, van Wijk F, et al.
Allergy
. 2021 Sep;
77(3):827-842.
PMID: 34559894
T lymphocytes (T cells) are major players of the adaptive immune response. Naive T cells are primed in the presence of cytokines, leading to polarization into distinct T-cell subsets with...
16.
Linnik D, Tarakanchikova Y, Zyuzin M, Lepik K, Aerts J, Sukhorukov G, et al.
Expert Opin Drug Deliv
. 2021 Feb;
18(8):1047-1066.
PMID: 33599154
: Gene therapy is a breakthrough medical field which focuses on the therapeutic delivery of recombinant nucleic acids in order to treat or prevent a broad spectrum of diseases. However,...
17.
Dhaese S, Lacroix C, Garcia F, Plana M, Ruta S, Vanham G, et al.
J Control Release
. 2020 Nov;
330:1016-1033.
PMID: 33181204
Over the last few years, immunotherapy for HIV in general and therapeutic vaccination in particular, has received a tremendous boost, both in preclinical research and in clinical applications. This interest...
18.
Serhan A, Aerts J, Boddeke E, Kooijman R
Neuroscience
. 2019 Dec;
426:101-114.
PMID: 31846748
We and others have shown that insulin-like growth factor-1 (IGF-1) is neuroprotective when administered systemically shortly following stroke. In the current study, we addressed the hypothesis that microglia mediate neuroprotection...
19.
Joe P, Christopoulou I, Van Hoecke L, Schepens B, Ysenbaert T, Heirman C, et al.
J Transl Med
. 2019 Jul;
17(1):242.
PMID: 31345237
Background: Current human influenza vaccines lack the adaptability to match the mutational rate of the virus and therefore require annual revisions. Because of extensive manufacturing times and the possibility that...
20.
Bialkowski L, Van der Jeught K, Bevers S, Joe P, Renmans D, Heirman C, et al.
Int J Cancer
. 2018 Feb;
143(3):686-698.
PMID: 29464699
Improved understanding of cancer immunology has provided insight into the phenomenon of frequent tumor recurrence after initially successful immunotherapy. A delicate balance exists between the capacity of the immune system...